FLSM
ERAS icon

Frazier Life Sciences Management’s Erasca ERAS Stock Holding History

Frazier Life Sciences Management’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458M Buy
24,975,188
+300,000
+1% +$4.29M 9.96% 3
2026
Q1 		$399M Buy
24,675,188
+1,945,752
+9% +$23M 10.27% 3
2025
Q4 		$84.6M Hold
22,729,436
– – 2.27% 11
2025
Q3 		$49.6M Hold
22,729,436
– – 1.48% 16
2025
Q2 		$28.9M Buy
22,729,436
+153,585
+0.7% +$206K 1.15% 19
2025
Q1 		$30.9M Buy
22,575,851
+3,184,164
+16% +$5.46M 1.41% 19
2024
Q4 		$48.7M Hold
19,391,687
– – 2.02% 12
2024
Q3 		$52.9M Buy
19,391,687
+3,175,471
+20% +$8.94M 2.12% 14
2024
Q2 		$38.3M Buy
+16,216,216
New +$35M 1.79% 17

Other funds holding ERAS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Frazier Life Sciences Management's ERAS Position: Q2 2026 in Review

Frazier Life Sciences Management increased its Erasca (ERAS) stake by 1.2% in Q2 2026, buying an estimated $4.29M and bringing the position to 24,975,188 shares worth $458M. The position accounts for 9.96% of the portfolio, ranked #3.

Frazier Life Sciences Management first reported a position in ERAS in Q2 2024 and has held it in 9 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Frazier Life Sciences Management held 24,975,188 shares of Erasca worth $458M as of Q2 2026.
  • Frazier Life Sciences Management bought 300,000 Erasca shares in Q2 2026, an estimated $4.29M.
  • Erasca made up 9.96% of Frazier Life Sciences Management's portfolio in Q2 2026, its #3 holding.
  • Frazier Life Sciences Management first reported a position in Erasca in Q2 2024 and has held it in 9 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.